-
VRTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Vertex Pharmaceuticals (VRTX)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.25 bn | 5.25 bn | 5.25 bn | 5.25 bn | 5.25 bn | 5.25 bn |
Cash burn (monthly) | 1.31 bn | 408.78 mm | (no burn) | (no burn) | 833.33 k | (no burn) |
Cash used (since last report) | 3.65 bn | 1.14 bn | n/a | n/a | 2.33 mm | n/a |
Cash remaining | 1.60 bn | 4.11 bn | n/a | n/a | 5.25 bn | n/a |
Runway (months of cash) | 1.2 | 10.0 | n/a | n/a | 6294.9 | n/a |
13F holders | Current |
---|---|
Total holders | 1502 |
Opened positions | 122 |
Closed positions | 137 |
Increased positions | 607 |
Reduced positions | 557 |
13F shares | Current |
---|---|
Total value | 101.94 tn |
Total shares | 230.66 mm |
Total puts | 1.36 mm |
Total calls | 1.58 mm |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
Capital World Investors | 26.81 mm | $12.47 tn |
Vanguard | 23.16 mm | $10.77 tn |
BLK BlackRock | 21.79 mm | $10.13 tn |
STT State Street | 11.82 mm | $5.50 tn |
FMR | 10.53 mm | $4.89 tn |
Capital Research Global Investors | 9.00 mm | $4.19 tn |
Alliancebernstein | 7.37 mm | $3.43 tn |
JPM JPMorgan Chase & Co. | 6.93 mm | $3.22 tn |
Geode Capital Management | 5.94 mm | $2.75 tn |
Jennison Associates | 5.55 mm | $2.58 tn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Nov 24 | Altshuler David | Common Stock | Sell | Dispose S | No | Yes | 478.56 | 15 | 7.18 k | 25,813 |
11 Nov 24 | Wagner Charles F JR | Common Stock | Sell | Dispose S | No | Yes | 518.27 | 3,000 | 1.55 mm | 44,137 |
8 Nov 24 | Kewalramani Reshma | Common Stock | Sell | Dispose S | No | Yes | 515 | 15,198 | 7.83 mm | 75,772 |
15 Oct 24 | Sachs Bruce I | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 484.39 | 90.32 | 43.75 k | 15,033.332 |
2 Oct 24 | Biller Jonathan | Common Stock | Sell | Dispose S | No | Yes | 461.66 | 999 | 461.20 k | 16,651 |
1 Oct 24 | Biller Jonathan | Common Stock | Payment of exercise | Dispose F | No | No | 466.84 | 630 | 294.11 k | 17,650 |